Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum.
about
Escherichia coli Subtilase CytotoxinIncorporation of a non-human glycan mediates human susceptibility to a bacterial toxinClathrin-dependent trafficking of subtilase cytotoxin, a novel AB5 toxin that targets the endoplasmic reticulum chaperone BiP.Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways.Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacementA dietary non-human sialic acid may facilitate hemolytic-uremic syndromeHemolytic uremic syndrome: pathogenesis and update of interventions.Fatal hemorrhage induced by subtilase cytotoxin from Shiga-toxigenic Escherichia coli.Inhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins Bax/Bak.In Vivo leukocyte changes induced by Escherichia coli subtilase cytotoxin.Structure, biological functions and applications of the AB5 toxins.Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.Differential effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on chemokine and proinflammatory cytokine expression in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.Recent advances in understanding enteric pathogenic Escherichia coli.Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infectionsUptake of Shiga-toxigenic Escherichia coli SubAB by HeLa cells requires an actin- and lipid raft-dependent pathway.Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cellsMolecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variantRegulation of subtilase cytotoxin-induced cell death by an RNA-dependent protein kinase-like endoplasmic reticulum kinase-dependent proteasome pathway in HeLa cellsIdentification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions.Subtilase cytotoxin induces apoptosis in HeLa cells by mitochondrial permeabilization via activation of Bax/Bak, independent of C/EBF-homologue protein (CHOP), Ire1alpha or JNK signaling.Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo.Decreased ER-associated degradation of alpha-TCR induced by Grp78 depletion with the SubAB cytotoxin.Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes.Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin.Cytotoxic and apoptotic effects of recombinant subtilase cytotoxin variants of shiga toxin-producing Escherichia coli.Plasmids from Shiga Toxin-Producing Escherichia coli Strains with Rare Enterohemolysin Gene (ehxA) Subtypes Reveal Pathogenicity Potential and Display a Novel Evolutionary Path.Targeting GRP78 to enhance melanoma cell death.T3SS-dependent microvascular thrombosis and ischemic enteritis in human gut xenografts infected with enteropathogenic Escherichia coli.Subtilase cytotoxin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli induces stress granule formation.Virulence characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples.Effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on primary cultures of human renal tubular epithelial cells.Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011.Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli.Prevalence of the operon encoding subtilase cytotoxin in non-O157 Shiga toxin-producing Escherichia coli isolated from humans in the United StatesNovel subtilase cytotoxin produced by Shiga-toxigenic Escherichia coli induces apoptosis in vero cells via mitochondrial membrane damage.Mechanism of inhibition of Shiga-toxigenic Escherichia coli SubAB cytotoxicity by steroids and diacylglycerol analogues.
P2860
Q24604606-1C4B4AF6-D7DD-4BF0-AA32-2BD6906F0863Q27652696-6D54E72E-49EC-437B-A683-50788BCB7868Q31137905-75209907-8C90-492F-99D9-10FB9BF3542BQ33330462-DD42567D-6D8B-47A0-974D-CB0C426CCA8CQ33383432-E589AA58-A035-45B9-A5CA-20D61204042EQ33384189-44604A43-0B52-403E-9A7D-26B762583DF5Q33385809-A0445FFE-0BAF-449D-8311-EE25CE6B1AA6Q33393643-10ED1ECF-D03D-413B-9515-07A85B6DEC00Q33408179-BE38B6BF-5190-47F6-8CED-32405C01401DQ33659904-493CB96E-ABCF-4343-BC4C-354F3DD80427Q33808158-9029C7AA-1DD3-4531-880B-BF4DA0D15DFDQ34102115-A7BBBFF4-F3AF-4D2E-9821-08644C78CF9EQ34172935-CCDDDD49-0E38-4662-8FB6-F8E8E540F353Q34298345-38079470-AD31-4C4D-8CA7-A24D475EEE4FQ34375210-83FE0F7A-008F-4B29-9FC1-85C22A4F2702Q34518407-98618C4E-566B-470E-9394-1629EA41C7BAQ34560475-D6D7DD5D-35B2-4CFA-8AD0-159E1E17724FQ34922868-2555F380-FAD3-46B8-AB50-651D1D275C33Q35017672-E6827F3A-4ECB-46EA-9C62-F09807407451Q35944091-716D8A7E-03CC-4798-BD79-F3ED3D3569CDQ36005317-9057C6CF-58EC-466B-A99B-91E370DE327BQ36060108-FCC64728-4329-4BFD-AC83-40E2AB167930Q36157952-B20FF872-9D84-4C3C-AB1D-C611BD137BADQ36915065-2B458B94-821F-47A1-9576-6632CA348B28Q36973217-D90E9E9E-E5F6-4157-9A52-95527B418472Q37389501-87730D42-BBD1-44BF-B20E-AD084F33B04FQ37402365-609956B4-40C1-472F-980D-D86E68A082F5Q38674148-B85F54E7-F107-4C9A-B369-443D768CE226Q38892889-26A699B2-960B-49DD-8B25-70295CB1D8A9Q39472250-38167085-E512-4812-B349-E6E490D8DCF5Q39693413-6FB4657D-A713-4A81-833A-9BEAA964F9C6Q40103041-B2E87134-69E6-4FBC-B0E3-8A00501CB894Q40839064-38BDF6B8-C3C7-4BB6-B0DC-90986D3D0B24Q41508665-C7638F98-8833-4229-B128-30676C495E2BQ41763522-7690C587-7A3B-4468-8F1B-4542B71731E7Q41896763-6EF00301-0827-45AF-9CA8-DA9A0335536EQ42076727-68BCE15F-FE0F-40FD-A5FB-5BFF6375B1C2Q42546155-31057C76-9935-4844-9F98-340949980DE8Q43097019-C887E3E4-4057-44BB-9921-88281D9DAEBDQ52659226-ECF527D4-D1F3-45C7-80C5-755CDC446602
P2860
Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@ast
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@en
type
label
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@ast
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@en
prefLabel
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@ast
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@en
P356
P1476
Pathologic changes in mice ind ...... ets the endoplasmic reticulum.
@en
P2093
James C Paton
P304
P356
10.1086/521364
P407
P577
2007-08-22T00:00:00Z